Ligand validation:4RJK

PYR: PYRUVIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4RJK_PYR_G_608	55%	8%	0.126	0.895	3.08	1.59	3	1	0	0	100%	1
4RJK_PYR_G_607	24%	6%	0.167	0.802	3.04	1.9	3	2	0	0	100%	1
4RJK_PYR_H_605	20%	9%	0.145	0.749	3.15	1.34	3	1	0	0	100%	1
4RJK_PYR_F_610	15%	7%	0.184	0.752	3.06	1.67	3	1	0	0	100%	1
4RJK_PYR_F_609	5%	5%	0.228	0.651	2.99	2.23	3	2	0	0	100%	1
4PLC_PYR_A_401	100%	34%	0.022	0.998	1.52	1	1	-	0	0	100%	1
3N25_PYR_C_1500	100%	6%	0.022	0.996	2.99	1.9	3	1	0	0	100%	1
7ETH_PYR_B_300	100%	8%	0.026	0.995	3.55	1.11	2	-	0	0	100%	1
3SRF_PYR_F_534	100%	43%	0.026	0.994	1.3	0.81	-	-	0	0	100%	1
7ETB_PYR_C_300	100%	17%	0.025	0.992	2.84	0.79	3	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.